Now showing items 1-1 of 1

    • Development of Dimethylisoxazole-Attached Imidazo[1,2‑a]pyridines as Potent and Selective CBP/P300 Inhibitors 

      Muthengi, Alex; Wimalasena, Virangika K.; Yosief, Hailemichael O.; Bikowitz, Melissa J.; Sigua, Logan H.; Wang, Tingjian; Li, Deyao; Zhang, Wei; Qi, Jun; Schönbrunn, Ernst; Amaro, Rommie E.; Erickson, Jon; Liu, Shuai; Dhawan, Gagan; Gaieb, Zied (2021)
      The use of epigenetic bromodomain inhibitors as anticancer therapeutics has transitioned from targeting bromodo main extraterminal domain (BET) proteins into targeting non-BET bromodomains. The two most relevant non-BET ...